ヘリオスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2017/07/20 | 1,517 | 1,519 | 1,503 | 1,513 | +3 | +0.2% | 33,200 |
| 2017/07/19 | 1,485 | 1,510 | 1,484 | 1,510 | +29 | +2% | 40,500 |
| 2017/07/18 | 1,518 | 1,525 | 1,478 | 1,481 | -37 | -2.4% | 109,700 |
| 2017/07/14 | 1,528 | 1,532 | 1,518 | 1,518 | -6 | -0.4% | 37,000 |
| 2017/07/13 | 1,544 | 1,545 | 1,523 | 1,524 | -20 | -1.3% | 48,500 |
| 2017/07/12 | 1,536 | 1,551 | 1,534 | 1,544 | +9 | +0.6% | 46,600 |
| 2017/07/11 | 1,548 | 1,560 | 1,528 | 1,535 | -5 | -0.3% | 92,400 |
| 2017/07/10 | 1,549 | 1,566 | 1,533 | 1,540 | -8 | -0.5% | 86,700 |
| 2017/07/07 | 1,574 | 1,575 | 1,541 | 1,548 | -21 | -1.3% | 160,600 |
| 2017/07/06 | 1,564 | 1,576 | 1,554 | 1,569 | +1 | +0.1% | 61,000 |
| 2017/07/05 | 1,560 | 1,573 | 1,550 | 1,568 | -9 | -0.6% | 59,500 |
| 2017/07/04 | 1,566 | 1,584 | 1,544 | 1,577 | +15 | +1% | 258,700 |
| 2017/07/03 | 1,551 | 1,569 | 1,545 | 1,562 | +23 | +1.5% | 130,800 |
| 2017/06/30 | 1,539 | 1,545 | 1,531 | 1,539 | ±0 | ±0% | 47,200 |
| 2017/06/29 | 1,542 | 1,552 | 1,530 | 1,539 | -1 | -0.1% | 44,700 |
| 2017/06/28 | 1,550 | 1,552 | 1,527 | 1,540 | +1 | +0.1% | 52,400 |
| 2017/06/27 | 1,535 | 1,568 | 1,533 | 1,539 | +3 | +0.2% | 59,100 |
| 2017/06/26 | 1,525 | 1,549 | 1,525 | 1,536 | +14 | +0.9% | 75,500 |
| 2017/06/23 | 1,570 | 1,573 | 1,513 | 1,522 | -47 | -3% | 114,500 |
| 2017/06/22 | 1,555 | 1,579 | 1,541 | 1,569 | +33 | +2.1% | 112,400 |
| 2017/06/21 | 1,532 | 1,553 | 1,530 | 1,536 | +5 | +0.3% | 74,100 |
| 2017/06/20 | 1,569 | 1,569 | 1,531 | 1,531 | -28 | -1.8% | 79,300 |
| 2017/06/19 | 1,561 | 1,564 | 1,535 | 1,559 | -11 | -0.7% | 63,200 |
| 2017/06/16 | 1,576 | 1,588 | 1,555 | 1,570 | -18 | -1.1% | 110,100 |
| 2017/06/15 | 1,526 | 1,589 | 1,509 | 1,588 | +64 | +4.2% | 349,900 |
| 2017/06/14 | 1,531 | 1,545 | 1,506 | 1,524 | -8 | -0.5% | 74,700 |
| 2017/06/13 | 1,481 | 1,534 | 1,481 | 1,532 | +53 | +3.6% | 156,400 |
| 2017/06/12 | 1,492 | 1,510 | 1,474 | 1,479 | -3 | -0.2% | 109,600 |
| 2017/06/09 | 1,487 | 1,495 | 1,475 | 1,482 | -3 | -0.2% | 55,100 |
| 2017/06/08 | 1,494 | 1,500 | 1,470 | 1,485 | +5 | +0.3% | 42,600 |
| 2017/06/07 | 1,475 | 1,498 | 1,469 | 1,480 | -1 | -0.1% | 85,900 |
| 2017/06/06 | 1,500 | 1,500 | 1,481 | 1,481 | -21 | -1.4% | 94,200 |
| 2017/06/05 | 1,537 | 1,538 | 1,500 | 1,502 | -14 | -0.9% | 122,500 |
| 2017/06/02 | 1,522 | 1,533 | 1,516 | 1,516 | +1 | +0.1% | 43,700 |
| 2017/06/01 | 1,505 | 1,518 | 1,500 | 1,515 | +5 | +0.3% | 50,100 |
| 2017/05/31 | 1,511 | 1,538 | 1,507 | 1,510 | -5 | -0.3% | 38,500 |
| 2017/05/30 | 1,528 | 1,550 | 1,507 | 1,515 | -39 | -2.5% | 97,800 |
| 2017/05/29 | 1,568 | 1,580 | 1,502 | 1,554 | -3 | -0.2% | 62,500 |
| 2017/05/26 | 1,588 | 1,588 | 1,553 | 1,557 | -18 | -1.1% | 32,100 |
| 2017/05/25 | 1,549 | 1,580 | 1,528 | 1,575 | +27 | +1.7% | 62,300 |
| 2017/05/24 | 1,562 | 1,571 | 1,524 | 1,548 | -20 | -1.3% | 80,600 |
| 2017/05/23 | 1,570 | 1,590 | 1,558 | 1,568 | -2 | -0.1% | 22,700 |
| 2017/05/22 | 1,606 | 1,606 | 1,570 | 1,570 | -27 | -1.7% | 45,600 |
| 2017/05/19 | 1,614 | 1,623 | 1,581 | 1,597 | -53 | -3.2% | 94,100 |
| 2017/05/18 | 1,550 | 1,660 | 1,534 | 1,650 | +31 | +1.9% | 107,600 |
| 2017/05/17 | 1,640 | 1,640 | 1,601 | 1,619 | -24 | -1.5% | 54,500 |
| 2017/05/16 | 1,653 | 1,657 | 1,641 | 1,643 | -3 | -0.2% | 27,700 |
| 2017/05/15 | 1,669 | 1,670 | 1,646 | 1,646 | -7 | -0.4% | 31,300 |
| 2017/05/12 | 1,652 | 1,668 | 1,651 | 1,653 | +2 | +0.1% | 19,100 |
| 2017/05/11 | 1,695 | 1,698 | 1,650 | 1,651 | -43 | -2.5% | 70,200 |
1901～
1950
件表示中 / 2415件
類似銘柄と比較する
現在ご覧いただいている「ヘリオス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ヘリオス | 32,300円 | +150.0% | - | 0.00% | - | 15.89倍 |
|
ｉＰＳ細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
| 生化学 | 70,700円 | +9.2% | +39.0% | 4.24% | 23.39倍 | 0.51倍 |
|
複合糖質で独自性。開発は関節疾患関連に特化。２種のヒアルロン酸製剤は科研と参天が販売 |
| 富士製薬 | 136,100円 | +15.7% | +5.3% | 3.34% | 9.84倍 | 0.73倍 |
|
女性医療、急性期医療の２領域に強い後発薬メーカー。注射剤が主体。新薬・バイオ後続品も |
| ダイト | 209,600円 | +4.5% | -33.7% | 3.34% | 21.11倍 | 0.61倍 |
|
医薬品の原薬製造販売や、製剤の製造受託が主力。ジェネリック（後発医薬品）メーカー向け強い |
| ミズホメディ | 150,300円 | +1.2% | -13.9% | 5.66% | 8.86倍 | 1.65倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
市場注目の銘柄
チャート関連のコラム
